The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival

Journal of Clinical Oncology

Volumn 30, Issue 13, 2012, Pages 1438-1446

  Warth, Arne ^a   Muley, Thomas ^b   Meister, Michael ^b   Stenzinger, Albrecht ^a   Thomas, Michael ^b   Schirmacher, Peter ^a   Schnabel, Philipp A ^a   Budczies, Jan ^c   Hoffmann, Hans ^b   Weichert, Wilko ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACINAR CELL CARCINOMA; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORPHOLOGY; OUTCOME ASSESSMENT; PAPILLOMA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID TUMOR; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CHI SQUARE DISTRIBUTION; CLASSIFICATION; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; DISEASE FREE SURVIVAL; EUROPE; KAPLAN MEIER METHOD; LUNG RESECTION; LUNG TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NOMENCLATURE; PATHOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ADENOCARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT SELECTION; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84860379332     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.2185     Document Type: Article

References (26)

1. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 60:277-300, 2010
2. Rami-Porta R, Bolejack V, Goldstraw P: The new tumor, node, and metastasis staging system. Semin Respir Crit Care Med 32:44-51, 2011
3. Kwak EL, Bang YJ, Camidge DR, et al: Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363:1693-1703, 2010
4. Rosell R, Moran T, Queralt C, et al: Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 361:958-967, 2009
5. Langer CJ, Besse B, Gualberto A, et al: The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol 28:5311-5320, 2010
6. Tomaszek SC, Huebner M, Wigle DA: Prospects for molecular staging of non-small-cell lung cancer from genomic alterations. Expert Rev Respir Med 4:499-508, 2010
7. Cross SS: Grading and scoring in histopathology. Histopathology 33:99-106, 1998
8. Gleason DF, Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58-64, 1974
9. Amin MB, Tamboli P, Merchant SH, et al: Micropapillary component in lung adenocarcinoma: A distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 26:358-364, 2002 (Pubitemid 34184460)
10. Barletta JA, Yeap BY, Chirieac LR: Prognostic significance of grading in lung adenocarcinoma. Cancer 116:659-669, 2010
11. Borczuk AC, Qian F, Kazeros A, et al: Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol 33:462-469, 2009
12. Miyoshi T, Satoh Y, Okumura S, et al: Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 27:101-109, 2003 (Pubitemid 36014903)
13. Motoi N, Szoke J, Riely GJ, et al: Lung adenocarcinoma: Modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 32:810-827, 2008
14. Noguchi M, Morikawa A, Kawasaki M, et al: Small adenocarcinoma of the lung: Histologic characteristics and prognosis. Cancer 75:2844-2852, 1995
15. Riquet M, Foucault C, Berna P, et al: Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Ann Thorac Surg 81:1988-1995, 2006 (Pubitemid 43775587)
16. Russell PA, Wainer Z, Wright GM, et al: Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 6:1496-1504, 2011
17. Sica G, Yoshizawa A, Sima CS, et al: A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol 34:1155-1162, 2010
18. Yim J, Zhu LC, Chiriboga L, et al: Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol 20:233-241, 2007 (Pubitemid 46422178)
19. Yoshizawa A, Motoi N, Riely GJ, et al: Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 24:653-664, 2011
20. Travis WD, Brambilla E, Noguchi M, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244-285, 2011
21. Travis WD, Brambilla E, Muller-Hermelink HK, et al: World Health Organization Classification of Tumors. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France, IARC Press, 2004
22. Aida S, Shimazaki H, Sato K, et al: Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types. Histopathology 45:468-476, 2004 (Pubitemid 39524321)
23. Yokose T, Suzuki K, Nagai K, et al: Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer 29:179-188, 2000
24. Weichert W, Warth A, Stenzinger A, et al: Interobserver variability in the application of the novel IASLC/ATS/ERS classification of lung adenocarcinoma. Virchows Arch 459:53, 2011
25. Miller VA, Hirsch FR, Johnson DH: Systemic therapy of advanced bronchioloalveolar cell carcinoma: Challenges and opportunities. J Clin Oncol 23:3288-3293, 2005 (Pubitemid 46211353)
26. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98, 2002 (Pubitemid 34438899)